As part of our ongoing aim to bring you reports of interesting new studies, we have added a review of a study titled: Long-term safety of Baricitinib in the treatment of Rheumatoid Arthritis; final results from an extension study and integrated database.
Independent expert commentary is provided by Professor Peter Nash, Professor in the School of Medicine at Griffith University, Queensland, and Director of the Rheumatology Research Unit on the Sunshine Coast.
Please login below to download this issue (PDF)